遺伝子組み換え療法の世界市場 2020年

• 英文タイトル：Global Genetic Modification Therapies Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115513 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、遺伝子組み換え療法の世界市場を調査対象にし、遺伝子組み換え療法の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（遺伝子治療、遺伝子組み換え細胞治療、RNA治療、遺伝子編集）、用途別分析（病院、診断及び試験研究所、学術及び研究機関、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：4D Molecular Therapeutics、American Gene Technologies、Abeona Therapeutics、Allergan、AbbVie、Merck Millipore ・企業別売上、市場シェア ・遺伝子組み換え療法の地域別市場分析 ・遺伝子組み換え療法の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・遺伝子組み換え療法のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・遺伝子組み換え療法のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・遺伝子組み換え療法の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・遺伝子組み換え療法の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・遺伝子組み換え療法の種類別市場規模2015-2020：遺伝子治療、遺伝子組み換え細胞治療、RNA治療、遺伝子編集 ・遺伝子組み換え療法の用途別市場規模2015-2020：病院、診断及び試験研究所、学術及び研究機関、その他 ・遺伝子組み換え療法の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Genetic Modification Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Genetic Modification Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Genetic Modification Therapies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Genetic Modification Therapies market has been segmented into:
Gene Therapies
Genetically Modified Cell Therapies
RNA Therapies
Gene Editing

By Application, Genetic Modification Therapies has been segmented into:
Hospitals
Diagnostics and Testing Laboratories
Academic and Research Organizations
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Genetic Modification Therapies market presented in the report. This section sheds light on the sales growth of different regional and country-level Genetic Modification Therapies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Genetic Modification Therapies market.

The report offers in-depth assessment of the growth and other aspects of the Genetic Modification Therapies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Genetic Modification Therapies Market Share Analysis
Genetic Modification Therapies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Genetic Modification Therapies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Genetic Modification Therapies sales, revenue and market share for each player covered in this report.

The major players covered in Genetic Modification Therapies are:
4D Molecular Therapeutics
American Gene Technologies
Abeona Therapeutics
Allergan
AbbVie
Merck Millipore

レポート目次

---

1 Genetic Modification Therapies Market Overview
1.1 Product Overview and Scope of Genetic Modification Therapies
1.2 Classification of Genetic Modification Therapies by Type
1.2.1 Global Genetic Modification Therapies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Genetic Modification Therapies Revenue Market Share by Type in 2019
1.2.3 Gene Therapies
1.2.4 Genetically Modified Cell Therapies
1.2.5 RNA Therapies
1.2.6 Gene Editing
1.3 Global Genetic Modification Therapies Market by Application
1.3.1 Overview: Global Genetic Modification Therapies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostics and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Global Genetic Modification Therapies Market by Regions
1.4.1 Global Genetic Modification Therapies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Genetic Modification Therapies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Genetic Modification Therapies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Genetic Modification Therapies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genetic Modification Therapies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Genetic Modification Therapies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genetic Modification Therapies Status and Prospect (2015-2025)
2 Company Profiles
2.1 4D Molecular Therapeutics
2.1.1 4D Molecular Therapeutics Details
2.1.2 4D Molecular Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 4D Molecular Therapeutics SWOT Analysis
2.1.4 4D Molecular Therapeutics Product and Services
2.1.5 4D Molecular Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.2 American Gene Technologies
2.2.1 American Gene Technologies Details
2.2.2 American Gene Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 American Gene Technologies SWOT Analysis
2.2.4 American Gene Technologies Product and Services
2.2.5 American Gene Technologies Genetic Modification Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abeona Therapeutics
2.3.1 Abeona Therapeutics Details
2.3.2 Abeona Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abeona Therapeutics SWOT Analysis
2.3.4 Abeona Therapeutics Product and Services
2.3.5 Abeona Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Genetic Modification Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Genetic Modification Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck Millipore
2.6.1 Merck Millipore Details
2.6.2 Merck Millipore Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck Millipore SWOT Analysis
2.6.4 Merck Millipore Product and Services
2.6.5 Merck Millipore Genetic Modification Therapies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Genetic Modification Therapies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Genetic Modification Therapies Players Market Share
3.2.2 Top 10 Genetic Modification Therapies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Genetic Modification Therapies Revenue and Market Share by Regions
4.2 North America Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
4.3 Europe Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
4.5 South America Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
5 North America Genetic Modification Therapies Revenue by Countries
5.1 North America Genetic Modification Therapies Revenue by Countries (2015-2020)
5.2 USA Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
5.3 Canada Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
5.4 Mexico Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
6 Europe Genetic Modification Therapies Revenue by Countries
6.1 Europe Genetic Modification Therapies Revenue by Countries (2015-2020)
6.2 Germany Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
6.3 UK Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
6.4 France Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
6.5 Russia Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
6.6 Italy Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Genetic Modification Therapies Revenue by Countries
7.1 Asia-Pacific Genetic Modification Therapies Revenue by Countries (2015-2020)
7.2 China Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
7.3 Japan Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
7.4 Korea Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
7.5 India Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
8 South America Genetic Modification Therapies Revenue by Countries
8.1 South America Genetic Modification Therapies Revenue by Countries (2015-2020)
8.2 Brazil Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
8.3 Argentina Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Genetic Modification Therapies by Countries
9.1 Middle East & Africa Genetic Modification Therapies Revenue by Countries (2015-2020)
9.2 Saudi Arabia Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
9.3 UAE Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
9.4 Egypt Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
9.5 South Africa Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Genetic Modification Therapies Revenue and Market Share by Type (2015-2020)
10.2 Global Genetic Modification Therapies Market Forecast by Type (2019-2024)
10.3 Gene Therapies Revenue Growth Rate (2015-2025)
10.4 Genetically Modified Cell Therapies Revenue Growth Rate (2015-2025)
10.5 RNA Therapies Revenue Growth Rate (2015-2025)
10.6 Gene Editing Revenue Growth Rate (2015-2025)
11 Global Genetic Modification Therapies Market Segment by Application
11.1 Global Genetic Modification Therapies Revenue Market Share by Application (2015-2020)
11.2 Genetic Modification Therapies Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostics and Testing Laboratories Revenue Growth (2015-2020)
11.5 Academic and Research Organizations Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Genetic Modification Therapies Market Size Forecast (2021-2025)
12.1 Global Genetic Modification Therapies Market Size Forecast (2021-2025)
12.2 Global Genetic Modification Therapies Market Forecast by Regions (2021-2025)
12.3 North America Genetic Modification Therapies Revenue Market Forecast (2021-2025)
12.4 Europe Genetic Modification Therapies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Genetic Modification Therapies Revenue Market Forecast (2021-2025)
12.6 South America Genetic Modification Therapies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Genetic Modification Therapies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Genetic Modification Therapies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Genetic Modification Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Genetic Modification Therapies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Genetic Modification Therapies Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. 4D Molecular Therapeutics Corporate Information, Location and Competitors
Table 6. 4D Molecular Therapeutics Genetic Modification Therapies Major Business
Table 7. 4D Molecular Therapeutics Genetic Modification Therapies Total Revenue (USD Million) (2017-2018)
Table 8. 4D Molecular Therapeutics SWOT Analysis
Table 9. 4D Molecular Therapeutics Genetic Modification Therapies Product and Solutions
Table 10. 4D Molecular Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. American Gene Technologies Corporate Information, Location and Competitors
Table 12. American Gene Technologies Genetic Modification Therapies Major Business
Table 13. American Gene Technologies Genetic Modification Therapies Total Revenue (USD Million) (2018-2019)
Table 14. American Gene Technologies SWOT Analysis
Table 15. American Gene Technologies Genetic Modification Therapies Product and Solutions
Table 16. American Gene Technologies Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Abeona Therapeutics Corporate Information, Location and Competitors
Table 18. Abeona Therapeutics Genetic Modification Therapies Major Business
Table 19. Abeona Therapeutics Genetic Modification Therapies Total Revenue (USD Million) (2017-2018)
Table 20. Abeona Therapeutics SWOT Analysis
Table 21. Abeona Therapeutics Genetic Modification Therapies Product and Solutions
Table 22. Abeona Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Allergan Corporate Information, Location and Competitors
Table 24. Allergan Genetic Modification Therapies Major Business
Table 25. Allergan Genetic Modification Therapies Total Revenue (USD Million) (2017-2018)
Table 26. Allergan SWOT Analysis
Table 27. Allergan Genetic Modification Therapies Product and Solutions
Table 28. Allergan Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AbbVie Corporate Information, Location and Competitors
Table 30. AbbVie Genetic Modification Therapies Major Business
Table 31. AbbVie Genetic Modification Therapies Total Revenue (USD Million) (2017-2018)
Table 32. AbbVie SWOT Analysis
Table 33. AbbVie Genetic Modification Therapies Product and Solutions
Table 34. AbbVie Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Millipore Corporate Information, Location and Competitors
Table 36. Merck Millipore Genetic Modification Therapies Major Business
Table 37. Merck Millipore Genetic Modification Therapies Total Revenue (USD Million) (2017-2018)
Table 38. Merck Millipore SWOT Analysis
Table 39. Merck Millipore Genetic Modification Therapies Product and Solutions
Table 40. Merck Millipore Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Genetic Modification Therapies Revenue (Million USD) by Players (2015-2020)
Table 42. Global Genetic Modification Therapies Revenue Share by Players (2015-2020)
Table 43. Global Genetic Modification Therapies Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Genetic Modification Therapies Revenue Market Share by Regions (2015-2020)
Table 45. North America Genetic Modification Therapies Revenue by Countries (2015-2020)
Table 46. North America Genetic Modification Therapies Revenue Market Share by Countries (2015-2020)
Table 47. Europe Genetic Modification Therapies Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Genetic Modification Therapies Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Genetic Modification Therapies Revenue by Countries (2015-2020)
Table 50. South America Genetic Modification Therapies Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Genetic Modification Therapies Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Genetic Modification Therapies Revenue Market Share by Countries (2015-2020)
Table 53. Global Genetic Modification Therapies Revenue (Million USD) by Type (2015-2020)
Table 54. Global Genetic Modification Therapies Revenue Share by Type (2015-2020)
Table 55. Global Genetic Modification Therapies Revenue Forecast by Type (2021-2025)
Table 56. Global Genetic Modification Therapies Revenue by Application (2015-2020)
Table 57. Global Genetic Modification Therapies Revenue Share by Application (2015-2020)
Table 58. Global Genetic Modification Therapies Revenue Forecast by Application (2021-2025)
Table 59. Global Genetic Modification Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Genetic Modification Therapies Picture
Figure 2. Global Genetic Modification Therapies Revenue Market Share by Type in 2019
Figure 3. Gene Therapies Picture
Figure 4. Genetically Modified Cell Therapies Picture
Figure 5. RNA Therapies Picture
Figure 6. Gene Editing Picture
Figure 7. Genetic Modification Therapies Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Diagnostics and Testing Laboratories Picture
Figure 10. Academic and Research Organizations Picture
Figure 11. Others Picture
Figure 12. Global Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Genetic Modification Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Genetic Modification Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Genetic Modification Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Genetic Modification Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Genetic Modification Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Genetic Modification Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Genetic Modification Therapies Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Genetic Modification Therapies Revenue Market Share in 2019
Figure 21. Global Top 10 Players Genetic Modification Therapies Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Genetic Modification Therapies Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Genetic Modification Therapies Revenue Market Share by Regions (2015-2020)
Figure 25. Global Genetic Modification Therapies Revenue Market Share by Regions in 2018
Figure 26. North America Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 27. Europe Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 29. South America Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 31. North America Genetic Modification Therapies Revenue Market Share by Countries (2015-2020)
Figure 32. North America Genetic Modification Therapies Revenue Market Share by Countries in 2019
Figure 33. USA Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 34. Canada Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 36. Europe Genetic Modification Therapies Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Genetic Modification Therapies Revenue Market Share by Countries in 2019
Figure 38. Germany Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 39. UK Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 40. France Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 41. Russia Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 42. Italy Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Genetic Modification Therapies Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Genetic Modification Therapies Revenue Market Share by Countries in 2019
Figure 45. China Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 46. Japan Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 47. Korea Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 48. India Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 50. South America Genetic Modification Therapies Revenue Market Share by Countries (2015-2020)
Figure 51. South America Genetic Modification Therapies Revenue Market Share by Countries in 2019
Figure 52. Brazil Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Genetic Modification Therapies Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Genetic Modification Therapies Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 57. UAE Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Genetic Modification Therapies Revenue and Growth Rate (2015-2020)
Figure 60. Global Genetic Modification Therapies Revenue Share by Type (2015-2020)
Figure 61. Global Genetic Modification Therapies Revenue Share by Type in 2019
Figure 62. Global Genetic Modification Therapies Market Share Forecast by Type (2021-2025)
Figure 63. Global Gene Therapies Revenue Growth Rate (2015-2020)
Figure 64. Global Genetically Modified Cell Therapies Revenue Growth Rate (2015-2020)
Figure 65. Global RNA Therapies Revenue Growth Rate (2015-2020)
Figure 66. Global Gene Editing Revenue Growth Rate (2015-2020)
Figure 67. Global Genetic Modification Therapies Revenue Share by Application (2015-2020)
Figure 68. Global Genetic Modification Therapies Revenue Share by Application in 2019
Figure 69. Global Genetic Modification Therapies Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Diagnostics and Testing Laboratories Revenue Growth Rate (2015-2020)
Figure 72. Global Academic and Research Organizations Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Genetic Modification Therapies Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Genetic Modification Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Genetic Modification Therapies Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Genetic Modification Therapies Revenue Market Forecast (2021-2025)
Figure 78. Europe Genetic Modification Therapies Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Genetic Modification Therapies Revenue Market Forecast (2021-2025)
Figure 80. South America Genetic Modification Therapies Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Genetic Modification Therapies Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---